Clinical and radiological outcomes of bioactive glass in the treatment of benign bone tumors: a retrospective study of 64 cases
Authors:
- Onur CetinOCOnur Cetin
- Afak SayarASAfak Sayar
Open Access
- 5 September 2025
- journal article
- Published by Kare Publishing in Turkish Journal of Trauma and Emergency Surgery
- Vol. 31 (9) , 920-924
Abstract
Benign and benign-aggressive bone tumors, though non-metastatic, may require surgical intervention due to pain, fracture risk, or functional impairment. In many cases, bone grafting may be required in benign or benign-aggressive bone tumors. Although autografts remain the gold standard, they present disadvantages, especially in pediatric patients. Synthetic alternatives such as bioactive glass (BG) have emerged as viable options. This study aims to evaluate the clinical and radiological outcomes of BG in the treatment of benign bone tumors. This retrospective single-center study evaluated 64 patients (71 procedures) treated with curettage and BG grafting for benign bone tumors between 2004 and 2023. Functional outcomes were assessed using the Musculoskeletal Tumor Society (MSTS) score, and radiological healing was evaluated using the Neer classification. The mean follow-up was 25.0+-12.6 months. Significant improvement was observed in MSTS scores (from 17.6+-4.8 to 28.1+-2.0; p<0.05). Neer classification indicated high union rates. Complications included tumor recurrence in four patients (five procedures), fractures in nine patients, and superficial infections in four patients. No deep infections or any other material-related adverse effects were reported. Bioactive glass is a safe and effective bone substitute for managing benign bone defects, especially in pediatric populations where autograft options are limited. Its osteoconductive durability, infection resistance, and compatibility with bone remodeling make it a strong alternative to traditional grafting techniques.Keywords
This publication has 17 references indexed in Scilit:
- Bioactive glass in cavitary bone defects: a comparative experimental study in rabbitsActa Ortopedica Brasileira, 2015
- A Comparative Study of Clinicopathological Features Between Simple Bone Cysts of the Calcaneus and the Long BoneFoot & Ankle International, 2014
- Bioactive glass granules: a suitable bone substitute material in the operative treatment of depressed lateral tibial plateau fractures: a prospective, randomized 1 year follow-up studyJournal of Materials Science: Materials in Medicine, 2011
- A prospective randomized 14‐year follow‐up study of bioactive glass and autogenous bone as bone graft substitutes in benign bone tumorsJournal of Biomedical Materials Research Part B: Applied Biomaterials, 2010
- Treatment of Unicameral Bone CystJournal of Bone and Joint Surgery, 2010
- Treatment of a recurrent aneurysmal bone cyst with bioactive glass in a child allows for good bone remodelling and growthBone, 2009
- Unicameral bone cysts treated by injection of bone marrow or methylprednisoloneThe Journal of Bone and Joint Surgery. British volume, 2002
- A System for the Functional Evaluation of Reconstructive Procedures After Surgical Treatment of Tumors of the Musculoskeletal SystemClinical Orthopaedics and Related Research, 1993
- Bioactive glass particulate material as a filler for bone lesionsJournal of Oral Rehabilitation, 1991
- SENN ON THE HEALING OF ASEPTIC BONE CAVITIES BY IMPLANTATION OF ANTISEPTIC DECALCIFIED BONEAnnals of Surgery, 1889